DPP4 and type 2 diabetes mellitus: At admission, the majority of type 2 diabetes patients taking OADs were on metformin either alone (380 [41%]) or in combination with DPP-4 inhibitors (287 [31%]), while 40 (4%) used DPP-4 inhibitors only.